Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berneburg, M.
Right arrow Articles by Lehmann, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berneburg, M.
Right arrow Articles by Lehmann, A. R.
[Cancer Research 60, 431-438, January 15, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

The Cancer-free Phenotype in Trichothiodystrophy Is Unrelated to Its Repair Defect1

Mark Berneburg, Peter H. Clingen2, Susan A. Harcourt, Jillian E. Lowe3, Elaine M. Taylor, Michael H. L. Green3, Jean Krutmann, Colin F. Arlett and Alan R. Lehmann4

MRC Cell Mutation Unit, Sussex University, Brighton BN1 9RR, United Kingdom [M. B, P. H. C, J. E. L, E. M. T, M. H. L. G, A. R. L.], and Department of Dermatology, Heinrich Heine University, D-40225 Düsseldorf, Germany [J. K.]

The DNA repair-deficient genetic disorders xeroderma pigmentosum (XP) and trichothiodystrophy (TTD) can both result from mutations in the XPD gene, the sites of the mutations differing between the two disorders. The hallmarks of XP are multiple pigmentation changes in the skin and a greatly elevated frequency of skin cancers, characteristics that are not seen in TTD. XP-D and most TTD patients have reduced levels of DNA repair, but some recent reports have suggested that the repair deficiencies in TTD cells are milder than in XP-D cells. We reported recently that inhibition of intracellular adhesion molecule-1 (ICAM-1) expression by UVB irradiation was similar in normal and TTD cells but increased in XP-D cells, suggesting a correlation between ICAM-1 inhibition and cancer proneness. In the first part of the current work, we have extended these studies and found several other examples, including XP-G and Cockayne syndrome cells, in which increased ICAM-1 inhibition correlated with cancer proneness. However, we also discovered that a subset of TTD cells, in which arg112 in the NH2-terminal region of the XPD protein is mutated to histidine, had an ICAM-1 response similar to that of XP-D cells. In the second part of the work, we have shown that TTD cells with this specific NH2-terminal mutation are more sensitive to UV irradiation than other TTDs, most of which are mutated in the COOH-terminal region, and are indistinguishable from XP-D cells in cell killing, incision breaks, and repair of cyclobutane pyrimidine dimers. Because the clinical phenotypes of these patients do not obviously differ from those of TTDs with mutations at other sites, we conclude that the lack of skin abnormalities in TTD is independent of the defective cellular responses to UV. It is likely to result from a transcriptional defect, which prevents the skin abnormalities from being expressed.




This article has been cited by other articles:


Home page
Cancer Res.Home page
V. Chigancas, K. M. Lima-Bessa, A. Stary, C. F.M. Menck, and A. Sarasin
Defective Transcription/Repair Factor IIH Recruitment to Specific UV Lesions in Trichothiodystrophy Syndrome
Cancer Res., August 1, 2008; 68(15): 6074 - 6083.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Marini, T. Nardo, M. Giannattasio, M. Minuzzo, M. Stefanini, P. Plevani, and M. M. Falconi
DNA nucleotide excision repair-dependent signaling to checkpoint activation
PNAS, November 14, 2006; 103(46): 17325 - 17330.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Chigancas, A. Sarasin, and C. F. M. Menck
CPD-photolyase adenovirus-mediated gene transfer in normal and DNA-repair-deficient human cells
J. Cell Sci., July 15, 2004; 117(16): 3579 - 3592.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. J. Stratigos and H. P. Baden
Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
Arch Dermatol, November 1, 2001; 137(11): 1465 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
B. C. Broughton, M. Berneburg, H. Fawcett, E. M. Taylor, C. F. Arlett, T. Nardo, M. Stefanini, E. Menefee, V. H. Price, S. Queille, et al.
Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene
Hum. Mol. Genet., October 1, 2001; 10(22): 2539 - 2547.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. R. Lehmann
The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases
Genes & Dev., January 1, 2001; 15(1): 15 - 23.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.